K
Kevin H Carroll
Researcher at AstraZeneca
Publications - 1
Citations - 2071
Kevin H Carroll is an academic researcher from AstraZeneca. The author has contributed to research in topics: Hazard ratio & Placebo. The author has an hindex of 1, co-authored 1 publications receiving 2044 citations.
Papers
More filters
Journal ArticleDOI
Gefitinib plus best supportive care in previously treated patients with refractory advanced non-small-cell lung cancer: results from a randomised, placebo-controlled, multicentre study (Iressa Survival Evaluation in Lung Cancer)
Nick Thatcher,Alex R. Chang,Purvish M. Parikh,José Rodrigues Pereira,Tudor Ciuleanu,Joachim von Pawel,Sumitra Thongprasert,Eng Huat Tan,Kristine Pemberton,Venice Archer,Kevin H Carroll +10 more
TL;DR: Treatment with gefitinib was not associated with significant improvement in survival in either coprimary population, and there was pronounced heterogeneity in survival outcomes between groups of patients, with some evidence of benefit among never-smokers and patients of Asian origin.